Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts

Archive ouverte

Liu, Ganqiang | Locascio, Joseph | Corvol, Jean-Christophe | Boot, Brendon | Liao, Zhixiang | Page, Kara | Franco, Daly | Burke, Kyle | Jansen, Iris | Trisini-Lipsanopoulos, Ana | Winder-Rhodes, Sophie | Tanner, Caroline | Lang, Anthony | Eberly, Shirley | Elbaz, Alexis | Brice, Alexis | Mangone, Graziella | Ravina, Bernard | Shoulson, Ira | Cormier-Dequaire, Florence | Heutink, Peter | van Hilten, Jacobus | Barker, Roger | Williams-Gray, Caroline | Marinus, Johan | Scherzer, Clemens | Hyman, Bradley | Ivinson, Adrian | Sudarsky, Lewis | Hayes, Michael | Umeh, Chizoba | Sperling, Reisa | Growdon, John | Schwarzschild, Michael | Hung, Albert | Flaherty, Alice | Blacker, Deborah | Wills, Anne-Marie | Sohur, U. Shivraj | Mejia, Nicte | Viswanathan, Anand | Gomperts, Stephen | Khurana, Vikram | Albers, Mark | Alora-Palli, Maria | Mcginnis, Scott | Sharma, Nutan | Dickerson, Bradford | Frosch, Matthew | Gomez-Isla, Teresa | Greenberg, Steven | Gusella, James | Hedden, Trey | Hedley-Whyte, E Tessa | Koenig, Aaron | Marquis-Sayagues, Marta | Marshall, Gad | Okereke, Olivia | Stemmer-Rachaminov, Anat | Kloppenburg, Jessica | Schlossmacher, Michael | Selkoe, Dennis | Yi, Thomas | Li, Haining | Stalberg, Gabriel | Foltynie, Tom | Robbins, Trevor | Brayne, Carol | Mason, Sarah | Breen, David | Cummins, Gemma | Evans, Jonathan | Mallet, Alain | Vidailhet, Marie | Bonnet, Anne-Marie | Bonnet, Cecilia | Grabli, David | Hartmann, Andreas | Klebe, Stephan | Lacomblez, Lucette | Bourdain, Frédéric | Brandel, Jean-Philippe | Derkinderen, Pascal | Durif, Franck | Mesnage, Valérie | Pico, Fernando | Rascol, Olivier | Brefel-Courbon, Christine | Ory-Magne, Fabienne | Forlani, Sylvie | Lesage, Suzanne | Tahiri, Khadija | Albin, Roger | Alcalay, Roy | Ascherio, Alberto | Bowman, Dubois | Chen-Plotkin, Alice | Dawson, Ted | Dewey, Richard | German, Dwight | Saunders-Pullman, Rachel | Vaillancourt, David | Petyuk, Vladislav | West, Andy | Zhang, Jing

Edité par CCSD ; Elsevier -

International audience. Summary Background Cognitive decline is a debilitating manifestation of disease progression in Parkinson’s disease. We aimed to develop a clinical-genetic score to predict global cognitive impairment in patients with the disease. Methods A prediction algorithm for global cognitive impairment (defined as Mini Mental State Exam (MMSE) ≤25) was built using data from 1,350 patients with 5,165 longitudinal visits over 12.8 (median, 2.8) years. Age at onset, MMSE, education, motor exam score, gender, depression and GBA mutations, machine selected through stepwise Cox’ hazards analysis and Akaike’s information criterion, were used to compute the multivariable predictor. Independent validation was achieved in another 1,132 patients with 19,127 visits over 8.6 (median, 6.5) years. Findings The cognitive risk score accurately predicted cognitive impairment within ten years of disease onset with an area under the curve (AUC) of >0.85 in both the discovery (95% CI, 0.821–0.902) and validation populations (95% CI, 0.779 – 0.913). 72.6% of patients scoring in the highest quartile were cognitively impaired by ten years vs. 3.7% in the lowest quartile (hazard ratio, 18.4, 95% CI, 9.4 – 36.1). Dementia or disabling cognitive impairment was predicted with an AUC of 0.877 (95% CI 0.788–0.943) and high negative predictive value (0.920, 95% 0.877–0.954) at the predefined cutoff (0.196). Performance was stable in 10,000 randomly resampled subsets. Interpretation Our predictive algorithm provides a potential test for future cognitive health or impairment in patients with Parkinson’s. It could improve trials of cognitive interventions and inform on prognosis.

Consulter en ligne

Suggestions

Du même auteur

Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease

Archive ouverte | Liu, Ganqiang | CCSD

International audience. A key driver of patients' well-being and clinical trials for Parkinson's disease (PD) is the course that the disease takes over time (progression and prognosis). To assess how genetic variati...

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's

Archive ouverte | Loiodice, Simon | CCSD

International audience

Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study

Archive ouverte | Ihle, J. | CCSD

International audience. Objective: To examine the relationship between a Parkinson's disease (PD) polygenic risk score (PRS) and impulse control disorders (ICDs) in PD. Background: Genome wide association studies (G...

Chargement des enrichissements...